论文部分内容阅读
目的观察倍他乐克对心肌梗塞患者院外生存质量的影响。方法选取63例心肌梗塞病情稳定出院后患者,随机分为倍他乐组与对照组,倍他乐克组每日口服倍他乐克50mg,连续服用24周,结果倍他乐克组再发病住院率、死亡率均明显下降(P<0.05)。结论倍他乐克可显著降低心肌梗塞患者院外再发病住院率、死亡率,提高心肌梗塞患者院外生存质量。
Objective To observe the effect of metoprolol on the quality of life of patients with myocardial infarction. Methods Sixty-three patients with stable myocardial infarction after discharge were randomly divided into metoprolol and control groups. Betaloc 50 mg orally daily for 24 weeks resulted in the recurrence of metoprolol Hospitalization and mortality were significantly decreased (P <0.05). Conclusions Betaloc can significantly reduce the incidence of hospitalization and mortality in outpatients with myocardial infarction and improve the quality of life outside of hospital with myocardial infarction.